KALA BIO, Inc.
KALA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479419
No open-market purchases or sales by KALA BIO, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.21M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in KALA BIO, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −1 vs. Q3 2023
- Shares held
- 525.9K
- +12.2K (+2.4%) vs. Q3 2023
- Total value
- $3.68M
- −$890.9K (−19.5%) vs. Q3 2023
- New holders
- 2
- 8 more added
- Sold out
- 3
- 3 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KALA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $1.21M |
| Q1 2026 | 30 | $294.0K |
| Q4 2025 | 32 | $1.58M |
| Q3 2025 | 24 | $2.69M |
| Q2 2025 | 30 | $17.3M |
| Q1 2025 | 29 | $23.7M |
| Q4 2024 | 33 | $24.0M |
| Q3 2024 | 27 | $12.1M |
| Q2 2024 | 29 | $14.8M |
| Q1 2024 | 29 | $4.88M |
| Q4 2023 | 25 | $3.68M |
| Q3 2023 | 26 | $4.57M |
| Q2 2023 | 30 | $5.56M |
| Q1 2023 | 26 | $4.81M |
| Q4 2022 | 30 | $12.8M |
| Q3 2022 | 56 | $1.36M |
| Q2 2022 | 70 | $2.27M |
| Q1 2022 | 88 | $33.7M |
| Q4 2021 | 85 | $30.9M |
| Q3 2021 | 108 | $79.5M |
| Q2 2021 | 107 | $171.3M |
| Q1 2021 | 118 | $248.9M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding KALA BIO, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 266,613 | $1.87M | 0.02% | 00.0% | Unchanged |
| Millennium Management LLC | 132,674 | $928.7K | 0.00% | −1,680−1.3% | Reduced |
| Vanguard Group Inc | 28,035 | $196.2K | 0.00% | +907+3.3% | Added |
| BlackRock Inc. | 27,321 | $191.2K | 0.00% | +1,222+4.7% | Added |
| Board of Trustees of The Leland Stanford Junior University | 21,127 | $147.9K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 18,465 | $129.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 14,100 | $99.0K | 0.00% | +14,100 | New |
| Knights of Columbus Asset Advisors LLC | 4,834 | $33.8K | 0.00% | +2,417+100.0% | Added |
| Tower Research Capital LLC (TRC) | 4,357 | $30.5K | 0.00% | +4,357 | New |
| Bank of America Corp | 2,587 | $18.1K | 0.00% | +2,472+2,149.6% | Added |
| Morgan Stanley | 1,621 | $11.4K | 0.00% | −32−1.9% | Reduced |
| Covestor Ltd | 1,262 | $9.00K | 0.01% | −63−4.8% | Reduced |
| Banque Cantonale Vaudoise | 808 | $6.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 696 | $4.87K | 0.00% | +551+380.0% | Added |
| Compagnie Lombard Odier SCmA | 400 | $2.80K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 296 | $2.07K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 241 | $1.69K | 0.00% | +7+3.0% | Added |
| CWM, LLC | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 120 | $840 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 31 | $217 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 17 | $119 | 0.00% | +1+6.3% | Added |
| Group One Trading, L.P. | 3 | $21 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 3 | $21 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 1 | $7 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 63 | $0 | 0.00% | +49+350.0% | Added |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −12,092−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Bank of New Hampshire | 0 | $0 | 0.00% | −1−100.0% | Sold out |